comparemela.com

Latest Breaking News On - Implants inc - Page 11 : comparemela.com

DGAP-Adhoc: aap Implantate AG: Q2 weaker than expected and adjustment of guidance for the financial year 2022 due to increased macroeconomic uncertainties in H2

DGAP-Ad-hoc: aap Implantate AG / Key word(s): Change in Forecast/Quarter Results aap Implantate AG: Q2 weaker than expected and adjustment of .

Germany
United-states
Berlin
Ukraine
German
Marek-hahn
Implants-inc
Standard-of-the-frankfurt-stock-exchange
Management-board
Regulated-market
German-stock-exchanges
General-standard

aap Implantate AG: Q2 weaker than expected and adjustment of guidance for the financial year 2022 du

aap Implantate AG / Key word(s): Change in Forecast/Quarter Resultsaap Implantate AG: Q2 weaker than expected and adjustment of guidance for the financial year 2022 due to increased macroeconomic uncertainties in H228-Jul-2022 / 17:29 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulati.

Germany
United-states
Berlin
Ukraine
German
Marek-hahn
Implants-inc
Standard-of-the-frankfurt-stock-exchange
Distribution-services
Management-board
Regulated-market
German-stock-exchanges

Turnaround in FY/2021: Significant sales growth (+30%) and substantially improved EBIDTA (+84%) - cl

DGAP-News: aap Implantate AG / Key word(s): Annual Results/Annual Report31.03.2022 / 07:20 The issuer is solely responsible for the content of this announcement. - Sales: EUR 12.2 million (+30% yoy) - CER[1]: +32% yoy; all markets with significant double-digit growth rates- EBITDA: EUR -0.8 million (+84% yoy);.

Puerto-rico
Germany
Mexico
United-states
Egypt
Brazil
China
Ecuador
South-africa
Colombia
Russia
Spain

DGAP-News: Successful completion of FY/2021 with +34% growth in Q4 leading to significant sales increase in 2021 (+30%); further sales growth and EBITDA improvement planned for FY/2022

DGAP-News: aap Implantate AG / Key word(s): Preliminary Results/Forecast Successful completion of FY/2021 with +34% growth in Q4 lead.

Mexico
Germany
Puerto-rico
United-states
Brazil
China
Ecuador
South-africa
Colombia
Spain
Berlin
America

Successful completion of FY/2021 with +34% growth in Q4 leading to significant sales increase in 202

DGAP-News: aap Implantate AG / Key word(s): Preliminary Results/Forecast24.01.2022 / 07:30 The issuer is solely responsible for the content of this announcement.- Sales +30% (FY/2021) to EUR 12.2 million and +34% (Q4) to EUR 3.2 million (CER[1]: +32% (FY/2021) and +38% (Q4))- Significant double-digit growth rates in.

Mexico
Germany
Puerto-rico
United-states
Brazil
China
Ecuador
South-africa
Colombia
Spain
Berlin
America

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.